Evaluation and Treatment of Amiodarone-Induced Thyroid Disorders
1
Endocrine Section, MedStar Washington Hospital Center, Washington, DC
|
Publication type: Journal Article
Publication date: 2020-11-07
scimago Q1
wos Q1
SJR: 2.183
CiteScore: 11.5
Impact factor: 5.1
ISSN: 0021972X, 19457197
PubMed ID:
33159436
Biochemistry
Clinical Biochemistry
Endocrinology
Endocrinology, Diabetes and Metabolism
Biochemistry (medical)
Abstract
Amiodarone is a class III antiarrhythmic drug containing 37% iodine by weight, with a structure similar to that of thyroid hormones. Deiodination of amiodarone releases large amounts of iodine that can impair thyroid function, causing either hypothyroidism or thyrotoxicosis in susceptible individuals reflecting ~20% of patients administered the drug. Not only the excess iodine, but also the amiodarone (or its metabolite, desethylamiodarone) itself may cause thyroid dysfunction by direct cytotoxicity on thyroid cells. We present an overview of the epidemiology and pathophysiology of amiodarone-induced thyroid disorders, with a focus on the various forms of clinical presentation and recommendations for personalized management of each form.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
1
2
3
4
|
|
|
Journal of Clinical Endocrinology and Metabolism
4 publications, 8.89%
|
|
|
Cureus
4 publications, 8.89%
|
|
|
L Endocrinologo
2 publications, 4.44%
|
|
|
Journal of Clinical Medicine
2 publications, 4.44%
|
|
|
Endocrine Practice
2 publications, 4.44%
|
|
|
AACE Endocrinology and Diabetes
2 publications, 4.44%
|
|
|
MMW Fortschritte der Medizin
1 publication, 2.22%
|
|
|
Endocrine
1 publication, 2.22%
|
|
|
Reactions Weekly
1 publication, 2.22%
|
|
|
CJC Open
1 publication, 2.22%
|
|
|
Endocrinology and Metabolism Clinics of North America
1 publication, 2.22%
|
|
|
Seminars in Nuclear Medicine
1 publication, 2.22%
|
|
|
Journal of Personalized Medicine
1 publication, 2.22%
|
|
|
Intensivmedizin up2date
1 publication, 2.22%
|
|
|
Evidence-based Complementary and Alternative Medicine
1 publication, 2.22%
|
|
|
The Clinician
1 publication, 2.22%
|
|
|
Medicina
1 publication, 2.22%
|
|
|
Clinical Thyroidology
1 publication, 2.22%
|
|
|
Journal of Clinical and Translational Endocrinology: Case Reports
1 publication, 2.22%
|
|
|
Journal of the American College of Cardiology
1 publication, 2.22%
|
|
|
Circulation
1 publication, 2.22%
|
|
|
The Lancet
1 publication, 2.22%
|
|
|
British journal of hospital medicine (London, England : 2005)
1 publication, 2.22%
|
|
|
Journal of Diabetes and Metabolic Disorders
1 publication, 2.22%
|
|
|
Endocrine Reviews
1 publication, 2.22%
|
|
|
Ultrastructural Pathology
1 publication, 2.22%
|
|
|
Frontiers in Pharmacology
1 publication, 2.22%
|
|
|
Current Molecular Medicine
1 publication, 2.22%
|
|
|
American Journal of Cardiovascular Drugs
1 publication, 2.22%
|
|
|
1
2
3
4
|
Publishers
|
2
4
6
8
10
12
14
|
|
|
Elsevier
13 publications, 28.89%
|
|
|
Springer Nature
12 publications, 26.67%
|
|
|
The Endocrine Society
5 publications, 11.11%
|
|
|
MDPI
4 publications, 8.89%
|
|
|
Georg Thieme Verlag KG
1 publication, 2.22%
|
|
|
Hindawi Limited
1 publication, 2.22%
|
|
|
Publishing House ABV Press
1 publication, 2.22%
|
|
|
Mary Ann Liebert
1 publication, 2.22%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
1 publication, 2.22%
|
|
|
Mark Allen Group
1 publication, 2.22%
|
|
|
Taylor & Francis
1 publication, 2.22%
|
|
|
Frontiers Media S.A.
1 publication, 2.22%
|
|
|
Bentham Science Publishers Ltd.
1 publication, 2.22%
|
|
|
Wiley
1 publication, 2.22%
|
|
|
2
4
6
8
10
12
14
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
45
Total citations:
45
Citations from 2024:
21
(46.66%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Ylli D. et al. Evaluation and Treatment of Amiodarone-Induced Thyroid Disorders // Journal of Clinical Endocrinology and Metabolism. 2020. Vol. 106. No. 1. pp. 226-236.
GOST all authors (up to 50)
Copy
Ylli D., Wartofsky L., Burman K. Evaluation and Treatment of Amiodarone-Induced Thyroid Disorders // Journal of Clinical Endocrinology and Metabolism. 2020. Vol. 106. No. 1. pp. 226-236.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1210/clinem/dgaa686
UR - https://doi.org/10.1210/clinem/dgaa686
TI - Evaluation and Treatment of Amiodarone-Induced Thyroid Disorders
T2 - Journal of Clinical Endocrinology and Metabolism
AU - Ylli, Dorina
AU - Wartofsky, Leonard
AU - Burman, Kenneth
PY - 2020
DA - 2020/11/07
PB - The Endocrine Society
SP - 226-236
IS - 1
VL - 106
PMID - 33159436
SN - 0021-972X
SN - 1945-7197
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2020_Ylli,
author = {Dorina Ylli and Leonard Wartofsky and Kenneth Burman},
title = {Evaluation and Treatment of Amiodarone-Induced Thyroid Disorders},
journal = {Journal of Clinical Endocrinology and Metabolism},
year = {2020},
volume = {106},
publisher = {The Endocrine Society},
month = {nov},
url = {https://doi.org/10.1210/clinem/dgaa686},
number = {1},
pages = {226--236},
doi = {10.1210/clinem/dgaa686}
}
Cite this
MLA
Copy
Ylli, Dorina, et al. “Evaluation and Treatment of Amiodarone-Induced Thyroid Disorders.” Journal of Clinical Endocrinology and Metabolism, vol. 106, no. 1, Nov. 2020, pp. 226-236. https://doi.org/10.1210/clinem/dgaa686.